- Home
- NEOG
NEOG
Neogen Corporation
as of 03-20-2026 3:55pm EST
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
| Founded: | 1981 | Country: | United States |
| Employees: | N/A | City: | LANSING |
| Market Cap: | 1.9B | IPO Year: | 1995 |
| Target Price: | $10.67 | AVG Volume (30 days): | 2.2M |
| Analyst Decision: | Buy | Number of Analysts: | 4 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.09 | EPS Growth: | -12475.00 |
| 52 Week Low/High: | $3.87 - $11.43 | Next Earning Date: | 04-08-2026 |
| Revenue: | $894,661,000 | Revenue Growth: | -3.20% |
| Revenue Growth (this year): | -3.03% | Revenue Growth (next year): | 1.67% |
| P/E Ratio: | 96.72 | Index: | N/A |
| Free Cash Flow: | 56.7M | FCF Growth: | N/A |
AI-Powered NEOG Daily Prediction
Machine learning model trained on 25+ technical indicators
AI Recommendation
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Neogen Corporation (NEOG)
CEO
Avg Cost/Share
$10.94
Shares
23
Total Value
$251.62
Owned After
704
SEC Form 4
CEO
Avg Cost/Share
$10.00
Shares
24
Total Value
$239.99
Owned After
704
SEC Form 4
CEO
Avg Cost/Share
$9.86
Shares
25
Total Value
$246.38
Owned After
704
SEC Form 4
CEO
Avg Cost/Share
$9.33
Shares
137
Total Value
$1,278.88
Owned After
704
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Nassif Mikheal | NEOG | CEO | Feb 17, 2026 | Buy | $10.94 | 23 | $251.62 | 704 | |
| Nassif Mikheal | NEOG | CEO | Feb 2, 2026 | Buy | $10.00 | 24 | $239.99 | 704 | |
| Nassif Mikheal | NEOG | CEO | Jan 26, 2026 | Buy | $9.86 | 25 | $246.38 | 704 | |
| Nassif Mikheal | NEOG | CEO | Jan 16, 2026 | Buy | $9.33 | 137 | $1,278.88 | 704 |
Earnings Transcripts
SEC 8-K filings with transcript text
2025 Q4 Q4 2025 Earnings
8-K SELL Jan 8, 2026 · 100% conf.
Q4 2025 Earnings
8-K SELLJan 8, 2026 · 100% conf.
1D
-0.39%
$9.66
Act: -0.21%
5D
-6.06%
$9.11
Act: -2.47%
20D
-3.01%
$9.41
Act: +11.34%
8-K
false0000711377Neogen Corporation00007113772026-01-082026-01-08
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 8, 2026
NEOGEN CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
0-17988
38-2367843
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
620 Lesher Place Lansing, Michigan
48912
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code 517-372-9200 SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.16 par value per share
NEOG
NASDAQ Global Select Market
N/A (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On January 8, 2026, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 second quarter ended November 30, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report, regardless of any general incorporation language in the filing. Item 9.01 Financial Statements and Exhibits (d)Exhibits
99.1
Press Release dated January 8, 2026
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEOGEN CORPORATION
(Registrant)
Date: January 8, 2026
/s/ R. Bryan Riggsbee
R. Bryan Riggsbee
Chief Financial Officer
2025 Q3 Q3 2025 Earnings
8-K Oct 9, 2025
Q3 2025 Earnings
8-KOct 9, 2025
8-K
0000711377falseNeogen Corporation00007113772025-10-092025-10-09
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) October 9, 2025
NEOGEN CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
0-17988
38-2367843
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
620 Lesher Place Lansing, Michigan
48912
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code 517-372-9200 SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.16 par value per share
NEOG
NASDAQ Global Select Market
N/A (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On October 9, 2025, Neogen Corporation issued a press release announcing results of operations for its fiscal 2026 first quarter ended August 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report, regardless of any general incorporation language in the filing. Item 9.01 Financial Statements and Exhibits (d)Exhibits
99.1
Press Release dated October 9, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEOGEN CORPORATION
(Registrant)
Date: October 9, 2025
/s/ David H. Naemura
David H. Naemura
Chief Financial & Operating Officer
2025 Q2 Q2 2025 Earnings
8-K Jul 29, 2025
Q2 2025 Earnings
8-KJul 29, 2025
8-K
0000711377falseNeogen Corporation00007113772025-07-292025-07-29
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) July 29, 2025
NEOGEN CORPORATION
(Exact name of registrant as specified in its charter)
Michigan
0-17988
38-2367843
(State or other jurisdiction of incorporation)
(Commission File Number)
(IRS Employer Identification No.)
620 Lesher Place Lansing, Michigan
48912
(Address of principal executive offices)
(Zip Code)
Registrant’s telephone number, including area code 517-372-9200 SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT:
Title of each Class
Trading Symbol(s)
Name of each exchange on which registered
Common Stock, $0.16 par value per share
NEOG
NASDAQ Global Select Market
N/A (Former name or former address, if changed since last report.)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 2.02 Results of Operations and Financial Condition On July 29, 2025, Neogen Corporation issued a press release announcing results of operations for its fiscal 2025 fourth quarter and twelve months ended May 31, 2025. A copy of the press release is attached as Exhibit 99.1 to this report. This Form 8-K and the attached exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and are not incorporated by reference into any filing of the Registrant, whether made before or after the date of this report, regardless of any general incorporation language in the filing. Item 9.01 Financial Statements and Exhibits (d)Exhibits
99.1
Press Release dated July 29, 2025
104
Cover Page Interactive Data File (embedded within the Inline XBRL document).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
NEOGEN CORPORATION
(Registrant)
Date: July 29, 2025
/s/ David H. Naemura
David H. Naemura
Chief Financial & Operating Officer
Compare NEOG vs Leading Stocks
See how NEOG stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "NEOG Neogen Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.